Theseus Pharmaceuticals Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Operating Revenue	18,116,411	18,181,001	17,179,994	13,953,627	11,732,029	10,663,731	Upgrade
Other Revenue	3,507,766	3,507,766	3,248,808	2,954,098	2,820,667	2,506,788	Upgrade
Revenue	21,624,177	21,688,767	20,428,802	16,907,725	14,552,696	13,170,519	Upgrade
Revenue Growth (YoY)	1.96%	6.17%	20.82%	16.18%	10.49%	-11.79%	Upgrade
Cost of Revenue	17,085,762	17,024,788	16,016,659	13,576,133	11,567,923	10,439,689	Upgrade
Gross Profit	4,538,415	4,663,979	4,412,143	3,331,592	2,984,773	2,730,830	Upgrade
Selling, General & Admin	2,388,921	2,351,011	2,106,539	1,669,908	1,326,485	1,331,728	Upgrade
Research & Development	1,176,543	1,099,482	923,627	880,915	787,056	738,894	Upgrade
Operating Expenses	3,565,464	3,450,493	3,030,166	2,550,823	2,113,541	2,070,622	Upgrade
Operating Income	972,951	1,213,486	1,381,977	780,769	871,232	660,208	Upgrade
Interest Expense	-56,593	-54,907	-59,631	-36,112	-16,867	-13,877	Upgrade
Interest & Investment Income	195,980	206,168	182,499	79,221	30,404	23,177	Upgrade
Earnings From Equity Investments	3,761	982	110,817	117,445	202,512	272,734	Upgrade
Currency Exchange Gain (Loss)	-22,009	-22,009	67,414	47,705	68,033	-26,163	Upgrade
Other Non Operating Income (Expenses)	-43,590	-26,080	-40,692	-109,463	-85,124	-2,026	Upgrade
EBT Excluding Unusual Items	1,050,500	1,317,640	1,642,384	879,565	1,070,190	914,053	Upgrade
Pretax Income	1,050,500	1,317,640	1,642,384	879,565	1,070,190	914,053	Upgrade
Income Tax Expense	346,899	414,606	459,794	162,256	309,489	218,609	Upgrade
Earnings From Continuing Operations	703,601	903,034	1,182,590	717,309	760,701	695,444	Upgrade
Minority Interest in Earnings	-65,754	-67,197	-75,416	-65,893	-53,634	-38,019	Upgrade
Net Income	637,847	835,837	1,107,174	651,416	707,067	657,425	Upgrade
Net Income to Common	637,847	835,837	1,107,174	651,416	707,067	657,425	Upgrade
Net Income Growth	-43.99%	-24.51%	69.96%	-7.87%	7.55%	44.25%	Upgrade
Shares Outstanding (Basic)	4,516	4,671	4,902	5,089	5,160	5,180	Upgrade
Shares Outstanding (Diluted)	4,516	4,671	4,902	5,089	5,160	5,180	Upgrade
Shares Change (YoY)	-7.17%	-4.70%	-3.68%	-1.38%	-0.39%	-1.45%	Upgrade
EPS (Basic)	141.24	178.93	225.88	128.01	137.03	126.92	Upgrade
EPS (Diluted)	141.24	178.93	225.88	128.01	137.03	126.92	Upgrade
EPS Growth	-39.66%	-20.79%	76.46%	-6.59%	7.97%	46.37%	Upgrade
Free Cash Flow	-41,119	-218,651	398,598	1,653,974	1,411,479	753,969	Upgrade
Free Cash Flow Per Share	-9.11	-46.81	81.32	325.01	273.55	145.56	Upgrade
Dividend Per Share	-	68.000	68.000	40.000	40.000	36.667	Upgrade
Dividend Growth	-	-	70.00%	-	9.09%	-1.79%	Upgrade
Gross Margin	20.99%	21.50%	21.60%	19.71%	20.51%	20.73%	Upgrade
Operating Margin	4.50%	5.59%	6.77%	4.62%	5.99%	5.01%	Upgrade
Profit Margin	2.95%	3.85%	5.42%	3.85%	4.86%	4.99%	Upgrade
Free Cash Flow Margin	-0.19%	-1.01%	1.95%	9.78%	9.70%	5.73%	Upgrade
EBITDA	1,420,830	1,670,679	1,868,878	1,502,399	1,482,295	1,284,447	Upgrade
EBITDA Margin	6.57%	7.70%	9.15%	8.89%	10.19%	9.75%	Upgrade
D&A For EBITDA	447,879	457,193	486,901	721,630	611,063	624,239	Upgrade
EBIT	972,951	1,213,486	1,381,977	780,769	871,232	660,208	Upgrade
EBIT Margin	4.50%	5.59%	6.77%	4.62%	5.99%	5.01%	Upgrade
Effective Tax Rate	33.02%	31.47%	28.00%	18.45%	28.92%	23.92%	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.